Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 3 de 3
Filter
Add more filters










Database
Language
Publication year range
1.
Med Mycol ; 50(8): 818-28, 2012 Nov.
Article in English | MEDLINE | ID: mdl-22587733

ABSTRACT

Invasive aspergillosis is a major cause of mortality in immunocompromised patients and therapeutic options are often limited, thus a vaccine would be desirable. We presently studied acid-stable cell-wall mannan (α-1, 6-linked backbone highly branched with α-1, 2; α-1, 3; and ß-1, 2-linked manno-oligomers) derived from C. albicans, with or without conjugation to bovine serum albumin (BSA), as a vaccine against systemic aspergillosis. Mice were vaccinated subcutaneously with mannan or mannan-BSA conjugate weekly 3 times, ending 2 weeks prior to infection with A. fumigatus conidia. Results showed that the protection induced by mannan is dose-dependent; 12 mg unconjugated mannan alone or > 0.3 mg mannan-BSA consistently enhanced survival (P < 0.05). Fungal burdens in brains and kidneys were reduced after > 0.3 mg of mannan-BSA (all P < 0.05). Mannan-induced protection was improved about 40-fold by conjugation of BSA to mannan. Mannan-BSA (500 kDa) was more protective than 40 kDa mannan-BSA. Mannan is a candidate for a cross-protective conjugate fungal vaccine.


Subject(s)
Aspergillosis/prevention & control , Fungal Vaccines/immunology , Mannans/immunology , Vaccination/methods , Animals , Aspergillosis/immunology , Candida albicans/chemistry , Candida albicans/immunology , Fungal Vaccines/administration & dosage , Male , Mannans/administration & dosage , Mannans/isolation & purification , Mice , Vaccines, Conjugate/administration & dosage , Vaccines, Conjugate/immunology
2.
Vaccine ; 29(9): 1745-53, 2011 Feb 17.
Article in English | MEDLINE | ID: mdl-21219976

ABSTRACT

Heat-killed Saccharomyces cerevisiae (HKY) used as a vaccine protects mice against systemic aspergillosis and coccidioidomycosis. Little is known about the immune response induced by HKY vaccination, consequently our goal was to do an analysis of HKY-induced immune responses involved in protection. BALB/c mice were vaccinated subcutaneously 3 times with HKY, a protective reagent, and bronchoalveolar lavage fluid, spleen, lymph nodes, and serum collected 2-5 weeks later. Cultured spleen or lymph node cells were stimulated with HKY. Proliferation of HKY-stimulated spleen or lymph node cells was tested by Alamar Blue reduction and flow cytometry. Cytokines from lymphocyte supernatants and antibody to glycans in serum collected from HKY-vaccinated mice were measured by ELISA. The results show that HKY promoted spleen cell and lymph node cell proliferation from HKY-vaccinated mice but not from PBS-vaccinated control mice (all P<0.05). Cytokine measurement showed HKY significantly promoted IFNγ, IL-6 and IL-17A production by spleen cells and lymph node cells (all P<0.05 and P<0.01, respectively). Cytokine production by HKY-stimulated cells from PBS-vaccinated mice was lower than those from HKY-vaccinated (P<0.05). Cytokines in BAL from HKY-vaccinated were higher, 1.7-fold for IFNγ and 2.1-fold for TNFα, than in BAL from PBS-vaccinated. Flow cytometry of lymphocytes from HKY-vaccinated showed 52% of CD3(+) or 56% of CD8(+) cells exhibited cell division after stimulation with HKY, compared to non-stimulated controls (26 or 23%, respectively) or HKY-stimulated cells from PBS-vaccinated (31 or 34%). HKY also induced antibody against Saccharomyces glucan and mannan with titers 4- or 2-fold, respectively, above that in unvaccinated. Taken together, the results suggested that HKY vaccination induces significant and specific Th1 type cellular immune responses and antibodies to glucan and mannan.


Subject(s)
Antigens, Fungal/immunology , Fungal Vaccines/immunology , Hot Temperature , Saccharomyces cerevisiae/immunology , Vaccines, Inactivated/immunology , Animals , Aspergillosis/immunology , Aspergillosis/prevention & control , Coccidioidomycosis/immunology , Coccidioidomycosis/prevention & control , Fungal Vaccines/administration & dosage , Lymph Nodes/cytology , Lymph Nodes/immunology , Lymph Nodes/microbiology , Male , Mice , Mice, Inbred BALB C , Spleen/cytology , Spleen/immunology , Spleen/microbiology , Vaccines, Inactivated/administration & dosage
3.
Glycoconj J ; 27(7-9): 697-702, 2010 Oct.
Article in English | MEDLINE | ID: mdl-21110087

ABSTRACT

A conjugate of C. dubliniensis cell-wall mannan and human serum albumin (HSA) induced significant level of anti-mannan IgGs in sera of immunized rabbits, whereas mannan alone was not immunogenic. Binding affinities of anti-mannan IgGs induced by the conjugate were evaluated by inhibition ELISA (iELISA) using mannooligosaccharides (dimer-octamer), derived from the side chains of C. dubliniensis mannan, as the inhibitors. Inhibition power of the mannooligosaccharides increased exponentially with their size, with dimer being the weakest (IC(50) = 4 mmol/L) and heptamer/octamer the strongest inhibitors (IC(50) = 0.01 mmol/L). In addition, the mannooligosaccharides proved effective as inhibitors against antiserum obtained from rabbits immunized with C. dubliniensis heat-killed cells, demonstrating a high correlation in the IC(50) values with anti-conjugate serum (Pearson's correlation coefficient r = 0.98; P < 0.01). These findings suggest that a) the mannooligosaccharides comprising the side chains of C. dubliniensis mannan may represent relevant points of interaction with host immune system during infection and b) anti-mannan antibodies induced by the two antigens (the mannan conjugate and the yeast) are of similar specificities.


Subject(s)
Candida/immunology , Fungal Vaccines/immunology , Mannans/immunology , Oligosaccharides/immunology , Animals , Cell Wall/chemistry , Cell Wall/immunology , Female , Fungal Vaccines/chemistry , Humans , Immune Sera , Immunoglobulin G/blood , Mannans/chemistry , Oligosaccharides/chemistry , Rabbits , Serum Albumin/immunology , Vaccines, Conjugate
SELECTION OF CITATIONS
SEARCH DETAIL
...